Tag: Health Costs
Volume-Based Compensation Most Common Incentive for Doctors
Quality and cost performance incentives were common, but percentage of compensation based on these was modest
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs
U.S. Insurers Could Spend Millions for Ivermectin Rx for COVID-19
Claims data for private insurance and Medicare Advantage plans show spike in inappropriate ivermectin prescriptions for COVID-19
Insurance Coverage for Acupuncture Up From 2010 to 2019
However, most costs are paid out of pocket
Major Financial Hardship Prevalent in Metastatic Colorectal Cancer
At 12 months, cumulative incidence of major financial hardship was 71.3 percent, despite insurance cover
13 Million Adults Delaying or Skipping Meds Due to Costs
Drug unaffordability is an issue regardless of insurance status and across private, public payers
Biogen Cuts Price of Controversial Aduhelm in Half
Drug shows promise in clearing brain plaques believed to play a role in Alzheimer disease
U.S. National Health Care Spending Increased 9.7 Percent in 2020
Increase was due to 36.0 percent increase in federal expenditures, mainly in response to COVID-19 pandemic
Pricey Alzheimer Drug Drives Spike in Medicare B Premium: Officials
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Cost-Sharing Waivers Did Not Cover All COVID-19 Hospital Care in 2020
Mean out-of-pocket spending was $3,840 for privately insured patients with COVID-19 hospitalizations
